A systematic rev1ew was conducted to evaluate the effectiveness of vaccination to reduce Salmonella prevalence in market weight finisher swine To identify relevant studies, online databases and selected conference proceed1ngs were searched. Two reviewers independently assessed the relevance screening and methodological quality of studies Data of characteristics of study population , 1ntervent1on, outcome, stat1st1cal analys1s, and results were extracted Four clinical trials and 21 challenge studies were 1dent1fied for the fina l review as they described vaccination to reduce Salmonella in swine Present evidence suggests that vaccmat1on IS associated w1lh reduced Salmonella prevalence 1n sw1ne
Introduction
Salmonella 1s cons1dered one of the maJOr foodborne pathogens transmitted by pork and pork products Vaccination is considered one method of reduc1ng pre-harvest Salmonella prevalence 1n swine The a1m of th1s systematic rev1ew was to appra1se and synthesize studies describing vaccination as a method of reducing Salmonella prevalence in market weight fimsher swme (Cook etal, 1997 , Sargeantetal , 2005 Materials and Methods
The review question was "What is the association between Salmonella prevalence in the antemortem or post-mortem animal ano vacc1nat1on agamst Salmonella 1n market we1ght fin1sher swine? A comprehensive literature search was conducted on online bibliographic databases Three maJor conference proceedings were searched by hand No language or publication restrictions for the searches were 1mposed lnclus1on criteria for relevance screemng were 1) pnmary research 1n English 2) Ph D theses 1n English, 3) Citations from conference proceedings, 4) descnbed evaluation of vaccmat1on agamst Salmonella in swine m a challenge tnal or clm1cal tnal and 5) reported ante-mortem or post-mortem presence of Salmonella in swine The methodological quality of all relevant studies was independently assessed by two rev1ewers usmg chec fists to assess challenge trials and clm1cal tnals Methodological grades of low/high were assigned based on the quality criteria Components of the quality assessment included objectives and study population intervention withdrawals and loss to follow-up, outcome assessment and data analys1s Data extraction mcluded the characteristics of population mtervent1on and level of allocat1on to treatment groups outcome. and results Only outcome5 describing ante-mortem or post-mortem culture of Salmonella post-vaccmat1on were extracted s
Results
Four clinical trials and 21 challenge studies that reported vacc1nation against Salmonella 1n swine were Identified for the final rev1ew. (Baum et al. , 1997; Charles et al. , 1999; Charles et al. , 2000a; Charles et al. , 2000b; Coe et al. , 1992; Draayer, 1986; Foster et al. , 2003; Gibson et al. , 1999; Gronmga et al. , 2000; Hanna et al. , 1979; Kennedy et al. , 1999; Kern, 1994; Kolb et al. , 2001 ; Kolb et al. , 2002; Kramer et al. , 1987; Kramer et al , 1992; Letellier et al. , 2000; Lumsden et al. , 1991 ; Maes et al. , 2001 ; Neubauer and Roof, 2005; Roesler et al. , 2004b; Roesler et al. , 2004a ; Roof and Do1tchinoff, 1995; Spnnger et al. , 2001 ) . Out of 25 studies, 18 and two studies were conducted m the USA and Canada , respectively, and five studies were conducted m Europe All four chn1cal trials reported isolat1on of Salmonella 1n market we1ght finisher swine, though received a low methodological quality grade All the challenge studies were conducted on age less than 15-weekold pigs while four of them received a high methodological quality grade .
Discussion
The majonty of studies reported a reduct1on in Salmonella assoc1ated with vaccmation using a variety of outcomes such as number of Salmonella pos1t1ve pigs or number of Salmonella pos1tive environmental samples. Some studies did not provide any data on the outcome effect other than a p value Most of the studies did not report study features which reduce b1as and mcrease mternal valid1ty, 1.e. random allocat1on of treatment un~ts or blinding at outcome assessment. Not all the studies tested for Salmonella status prior to the mtervention.
Conclusion
The present evidence suggests that vacc1nat1on against Salmonella IS assoc1ated w1th reduced level of Salmonella prevalence in fin~sher swme. However, many of the studies 1n the rev1ew d1d not to include Information that would have increased the evidentiary value of the papers 1n answenng the rev1ew quest1on .
